Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other bioactive molecules. Its structure supports chiral synthesis, making it valuable in creating enantiomerically pure drugs. Commonly employed in solid-phase peptide synthesis due to the Fmoc group, which allows for mild deprotection conditions. Also utilized in the preparation of enzyme inhibitors and receptor ligands in medicinal chemistry research.